Literature DB >> 6756017

Regional differences in lung function during anaesthesia and intensive care: clinical implications.

G Hedenstierna, J Santesson, L Bindslev, S Baehrendtz, C Klingstedt, O Norlander.   

Abstract

Anaesthesia and most frequently acute respiratory failure are accompanied by a lowered functional residual capacity (FRC). This lowering promotes airway closure in dependent lung units and forces ventilation to non-dependent regions. Perfusion, on the other hand, is forced towards dependent lung units. A ventilation-perfusion mismatch is created and hypoxaemia may develop. General PEEP counters airway closure, but impedes cardiac output and forces perfusion further to dependent regions. In addition, barotrauma may occur. Improved matching of ventilation and perfusion can be achieved by: (1) positioning the subject in the lateral posture; (2) ventilating each lung separately in proportion to its perfusion (differential ventilation); and (3) applying PEEP only to the dependent lung (selective PEEP). Because of less overall intrathoracic pressure and lung expansion, interference with the total lung blood flow and the danger of barotrauma should be less than with general PEEP. Improved gas exchange with a 50-100% increase in PaO2 has been observed in a limited number of patients with acute bilateral lung disease studied so far during differential ventilation and selective PEEP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6756017     DOI: 10.1111/j.1399-6576.1982.tb01794.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  2 in total

1.  Pulmonary function after extracorporeal shock wave lithotripsy--a comparison of general and regional anaesthesia.

Authors:  R E Kelly; M Binion; V Malhotra; J F Artusio
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

2.  Differential ventilation with selective PEEP in bilateral lung disease.

Authors:  C Frostell; H Blomqvist; J A Nilsson; C Grenrot; S Baehrendtz; G Hedenstierna
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.